Astellas Pharma Inc.

In News

Astellas Pharma Inc's Dividend Analysis - Yahoo Finance

Yahoo Finance - Sep 29, 2026

Astellas enters voluntary agreement with U.S. government supporting affordable access to medicines - PR Newswire

PR Newswire - Aug 31, 2026

Astellas Deploys Structure Prediction AI "Boltz-2 NIM" to Democratize and Accelerate Drug Discovery - NVIDIA

NVIDIA - Jul 10, 2026

Drugmaker Astellas looks to sell U.S. headquarters in Northbrook - Crain's Chicago Business

Crain's Chicago Business - Sep 23, 2026

Astellas Pharma Inc. Research & Ratings | 4503 - Barron's

Barron's - Oct 06, 2026

Astellas CEO wants more from Cambridge R&D as company faces patent cliff - The Business Journals

The Business Journals - Aug 09, 2026

Asian Market Highlights 3 Value Stocks Priced Below Estimated Worth - Simply Wall Street

Simply Wall Street - Oct 14, 2026

Diluted net income available to common stockholders of Astellas Pharma Inc. – HAN:YPH - TradingView

TradingView - Sep 29, 2026

Astellas Pharma Inc. 2027 Q1 - Results - Earnings Call Presentation (OTCMKTS:ALPMY) 2026-08-05 - Seeking Alpha

Seeking Alpha - Aug 05, 2026

Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas - Fierce Pharma

Fierce Pharma - Aug 12, 2026

Researchers will present the longest follow-up yet on a bladder cancer drug combination in Madrid. - Stock Titan

Stock Titan - Oct 06, 2026

India's Lupin settles US patent dispute with Astellas Pharma for $90 million - Reuters

Reuters - Feb 10, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment